L27.9
Dermatitis due to unspecified substance taken internally
Clinical Classification Guidelines
Medical Intelligence & Overview
Dermatitis due to unspecified substance taken internally, classified under ICD-10 code L27.9, is a skin condition that arises when an individual has an allergic or irritant reaction after consuming an unidentified substance. This type of dermatitis can manifest in various parts of the body, typically caused by allergic responses or sensitivity to substances ingested internally, such as medications, supplements, or other ingestible agents. Recognizing the symptoms and understanding potential causes can help in managing and seeking appropriate medical care for this condition.
Causes & Symptoms
Clinical Causes: Allergic reactions to medications or supplements consumed orally Sensitivity to certain food ingredients or additives Ingestion of toxic or irritant substances that trigger skin reactions Unidentified or undisclosed substances in herbal or traditional medicines Hidden exposure to chemicals in contaminated food or drinks
Key Symptoms: Redness and inflammation of the skin (erythema) Itching or pruritus in affected areas Swelling or edema of the skin Blister formation or oozing lesions Dryness, flaking, or scaling of the skin Localized or widespread rash
Diagnostic & Treatment
Diagnosis Path: Diagnosing dermatitis due to unspecified substances involves a combination of medical history review, physical examination, and possibly allergy testing. Healthcare providers may ask about recent ingestion of new foods, medicines, or supplements. They may also recommend allergy tests or patch testing to identify potential allergens. In some cases, elimination diets or tests may be necessary to pinpoint the exact internal substance responsible for the dermatitis.
Treatment Protocols: Managing this condition often focuses on alleviating symptoms and avoiding exposure to the offending substance. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is L27.9 a billable ICD-10 code?
Yes, L27.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L27.9?
Clinical documentation must specify the nature of Dermatitis due to unspecified substance taken internally and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
